首页 > 最新文献

Vascular最新文献

英文 中文
Endovascular abdominal aortic aneurysm repair (EVAR) outcomes of unibody and single/double docking limb endografts in Medicare beneficiaries between 2012 and 2018. 2012 年至 2018 年期间,医疗保险受益人使用单体和单/双对接肢内膜移植物进行血管内腹主动脉瘤修补术(EVAR)的疗效。
IF 1 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-11-13 DOI: 10.1177/17085381241300131
Mark F Conrad, Ami Sood, Alex O'Brien, Sapna Prasad, Erik Zendejas, Matt Thompson

Objective: The evaluation of perioperative and long term outcomes for endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAA) using anatomic (unibody) and proximal neck fixated (docking limbs) endografts across consecutive time cohorts.

Design: This study compares the outcomes of EVAR in Medicare patients stratified by mode of fixation.

Methods: All patients who underwent EVAR between 2012 and 2018 were identified in the Medicare database. Anatomic fixation (AF) and proximal fixation (PF) grafts were differentiated using Current Procedural Terminology (CPT) codes. The AF population was divided into three-time cohorts based on iterative changes in graft design: Cohort 1: (01/01/2012-20/07/2014); Cohort 2: (21/07/2014-09/05/2016); and Cohort 3: (10/05/2016-31/12/2017). The PF cohort was similarly divided into these three periods. Outcomes were evaluated through 31/12/2020 and included all-cause mortality, aortic rupture, and aortic-related reintervention.

Results: 32,031 patients underwent EVAR during the study period; 4729 were AF and 27,302 were PF. There were more women (p < .001) and patients with peripheral vascular disease (PVD) (p < .001) in the AF group. There were no group differences in perioperative outcomes. In Cohort 1, there was a higher rate of reintervention (11.9% vs 7.6%; p < .001) and aortic rupture (5.3% vs 4.0%; p = .019) in the AF group compared to the PF group. In Cohort 2, reintervention, aortic rupture, and reintervention rates were similar between the two groups (p = NS). In Cohort 3, the reintervention and aortic rupture rates were similar between the two groups (p = NS).

Conclusion: The higher rates of aortic rupture and reintervention seen in the AF group in Cohort 1 when compared with the PF group did not persist in Cohorts 2 and 3. This suggests that improvements in graft design may have led to durability which is similar to that of PF grafts. However, late aneurysm related complications are inherent risks after EVAR and long-term surveillance remains necessary.

目的:评估使用解剖型(单体)和近端颈部固定型(对接肢)内移植物进行腹主动脉瘤(AAA)血管内动脉瘤修补术(EVAR)的围术期和长期疗效:本研究比较了按固定方式分层的医疗保险患者的 EVAR 结果:所有在 2012 年至 2018 年期间接受 EVAR 的患者均在医疗保险数据库中进行了识别。使用当前程序术语(CPT)代码对解剖固定(AF)和近端固定(PF)移植物进行区分。根据移植物设计的迭代变化,将 AF 群体分为三个队列:队列 1:(01/01/2012-20/07/2014);队列 2:(21/07/2014-09/05/2016);队列 3:(10/05/2016-31/12/2017)。PF 组群同样分为这三个时期。结果评估至2020年12月31日,包括全因死亡率、主动脉破裂和主动脉相关再介入:研究期间有 32031 名患者接受了 EVAR,其中 4729 人为房颤患者,27302 人为 PF 患者。房颤组中女性(p < .001)和外周血管疾病(PVD)患者(p < .001)更多。围手术期结果没有组间差异。在队列 1 中,房颤组的再介入率(11.9% vs 7.6%; p < .001)和主动脉破裂率(5.3% vs 4.0%; p = .019)高于 PF 组。在队列 2 中,两组的再介入率、主动脉破裂率和再介入率相似(p = NS)。在队列 3 中,两组的再介入率和主动脉破裂率相似(P = NS):结论:与主动脉瓣置换术组相比,主动脉瓣置换术组的主动脉破裂率和再介入率较高,但这一现象在第二组和第三组中并未持续。这表明移植物设计的改进可能导致其耐用性与 PF 移植物相似。然而,EVAR术后动脉瘤相关的晚期并发症是固有的风险,因此仍有必要进行长期监测。
{"title":"Endovascular abdominal aortic aneurysm repair (EVAR) outcomes of unibody and single/double docking limb endografts in Medicare beneficiaries between 2012 and 2018.","authors":"Mark F Conrad, Ami Sood, Alex O'Brien, Sapna Prasad, Erik Zendejas, Matt Thompson","doi":"10.1177/17085381241300131","DOIUrl":"https://doi.org/10.1177/17085381241300131","url":null,"abstract":"<p><strong>Objective: </strong>The evaluation of perioperative and long term outcomes for endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAA) using anatomic (unibody) and proximal neck fixated (docking limbs) endografts across consecutive time cohorts.</p><p><strong>Design: </strong>This study compares the outcomes of EVAR in Medicare patients stratified by mode of fixation.</p><p><strong>Methods: </strong>All patients who underwent EVAR between 2012 and 2018 were identified in the Medicare database. Anatomic fixation (AF) and proximal fixation (PF) grafts were differentiated using Current Procedural Terminology (CPT) codes. The AF population was divided into three-time cohorts based on iterative changes in graft design: Cohort 1: (01/01/2012-20/07/2014); Cohort 2: (21/07/2014-09/05/2016); and Cohort 3: (10/05/2016-31/12/2017). The PF cohort was similarly divided into these three periods. Outcomes were evaluated through 31/12/2020 and included all-cause mortality, aortic rupture, and aortic-related reintervention.</p><p><strong>Results: </strong>32,031 patients underwent EVAR during the study period; 4729 were AF and 27,302 were PF. There were more women (<i>p</i> < .001) and patients with peripheral vascular disease (PVD) (<i>p</i> < .001) in the AF group. There were no group differences in perioperative outcomes. In Cohort 1, there was a higher rate of reintervention (11.9% vs 7.6%; <i>p</i> < .001) and aortic rupture (5.3% vs 4.0%; <i>p</i> = .019) in the AF group compared to the PF group. In Cohort 2, reintervention, aortic rupture, and reintervention rates were similar between the two groups (p = NS). In Cohort 3, the reintervention and aortic rupture rates were similar between the two groups (p = NS).</p><p><strong>Conclusion: </strong>The higher rates of aortic rupture and reintervention seen in the AF group in Cohort 1 when compared with the PF group did not persist in Cohorts 2 and 3. This suggests that improvements in graft design may have led to durability which is similar to that of PF grafts. However, late aneurysm related complications are inherent risks after EVAR and long-term surveillance remains necessary.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381241300131"},"PeriodicalIF":1.0,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142629070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Giant renal artery aneurysm with severe compression of the right kidney. 巨大肾动脉瘤严重压迫右肾。
IF 1 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-11-07 DOI: 10.1177/17085381241299190
Haibo Wang, Mingwei Wu, Jiang Xiong

Objectives: Renal artery aneurysm (RAA) is a rare condition among visceral aneurysms, often asymptomatic and incidentally discovered through imaging. Surgical or interventional procedures are utilized for treatment, depending on the aneurysm's size, morphology, and the patient's physical condition, to prevent rupture.

Methods: A patient was admitted with a giant asymptomatic RAA, measuring a maximum diameter of 11 cm on a serendipitous occasion.

Results: We successfully accomplished a full embolization treatment for the aneurysm, exclusively utilizing inflow tract embolization techniques. Six months post-treatment, a follow-up abdominal ultrasound examination demonstrated a notable decrease in the aneurysm's diameter, signifying the positive outcome of our intervention.

Conclusions: This approach offers a feasible alternative in challenging cases, especially when traditional surgical methods are not feasible or carry significant risks.

目的:肾动脉瘤(RAA)是内脏动脉瘤中的一种罕见疾病,通常无症状,通过影像学检查偶然发现。根据动脉瘤的大小、形态和患者的身体状况,采用外科手术或介入手术进行治疗,以防止破裂:方法:一名患者因巨大无症状 RAA 而入院,其最大直径达 11 厘米:结果:我们完全采用流入道栓塞技术,成功完成了动脉瘤的完全栓塞治疗。治疗后六个月,腹部超声波随访检查显示动脉瘤直径明显缩小,这表明我们的干预取得了积极成果:这种方法为具有挑战性的病例提供了一种可行的替代方案,尤其是在传统手术方法不可行或存在重大风险的情况下。
{"title":"Giant renal artery aneurysm with severe compression of the right kidney.","authors":"Haibo Wang, Mingwei Wu, Jiang Xiong","doi":"10.1177/17085381241299190","DOIUrl":"https://doi.org/10.1177/17085381241299190","url":null,"abstract":"<p><strong>Objectives: </strong>Renal artery aneurysm (RAA) is a rare condition among visceral aneurysms, often asymptomatic and incidentally discovered through imaging. Surgical or interventional procedures are utilized for treatment, depending on the aneurysm's size, morphology, and the patient's physical condition, to prevent rupture.</p><p><strong>Methods: </strong>A patient was admitted with a giant asymptomatic RAA, measuring a maximum diameter of 11 cm on a serendipitous occasion.</p><p><strong>Results: </strong>We successfully accomplished a full embolization treatment for the aneurysm, exclusively utilizing inflow tract embolization techniques. Six months post-treatment, a follow-up abdominal ultrasound examination demonstrated a notable decrease in the aneurysm's diameter, signifying the positive outcome of our intervention.</p><p><strong>Conclusions: </strong>This approach offers a feasible alternative in challenging cases, especially when traditional surgical methods are not feasible or carry significant risks.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381241299190"},"PeriodicalIF":1.0,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thirty-day outcomes of endovascular repair of Stanford type B aortic dissection in patients with chronic obstructive pulmonary disease. 慢性阻塞性肺病患者斯坦福B型主动脉夹层血管内修复术后30天的疗效。
IF 1 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-11-05 DOI: 10.1177/17085381241298732
Renxi Li, Anton Sidawy, Bao-Ngoc Nguyen

Background: Thoracic Endovascular Aortic Repair (TEVAR) has revolutionized the surgical treatment for Stanford type B aortic dissection (TBAD). While chronic obstructive pulmonary disease (COPD) is associated with worse outcomes in major surgeries, the specific outcomes of TEVAR in patients with COPD have not been extensively explored. This study aimed to evaluate the 30-day postoperative outcomes of COPD patients undergoing TEVAR for TBAD utilizing data from a multi-institutional national registry.

Methods: Patients who underwent TEVAR for TBAD were identified in the ACS-NSQIP database from 2005 to 2022. A 1:3 propensity-score matching was used to match demographics and preoperative characteristics between patients with and without COPD. Thirty-day postoperative outcomes were compared.

Results: There were 172 (9.56%) and 1628 (90.44%) COPD and non-COPD patients who underwent TEVAR for TBAD, respectively. Patients with COPD had a higher comorbidity burden. After the propensity-score matching, all 172 COPD patients were matched to 440 non-COPD patients. COPD and non-COPD patients had comparable mortality rates (10.12% vs 6.82%, p = .18). However, COPD patients had a higher risk of pulmonary complications (20.83% vs 13.18%, p = .02). All other 30-day outcomes were similar between the two groups.

Conclusion: COPD patients had 58.04% higher pulmonary complications while all other 30-day outcomes were comparable to their non-COPD counterparts. Therefore, close monitoring and timely intervention for pulmonary complications in COPD patients can be important after TEVAR for TBAD. Future studies should investigate long-term outcomes among these COPD patients.

背景:胸腔内血管主动脉修复术(TEVAR)彻底改变了斯坦福B型主动脉夹层(TBAD)的手术治疗方法。虽然慢性阻塞性肺病(COPD)与重大手术的不良预后有关,但 TEVAR 对 COPD 患者的具体预后尚未得到广泛探讨。本研究旨在利用多机构国家登记处的数据,评估因 TBAD 而接受 TEVAR 手术的 COPD 患者术后 30 天的预后:方法:2005 年至 2022 年期间,在 ACS-NSQIP 数据库中确定了接受 TEVAR 治疗 TBAD 的患者。采用1:3倾向得分匹配法对有慢性阻塞性肺病和无慢性阻塞性肺病的患者进行人口统计学和术前特征匹配。对术后30天的结果进行了比较:分别有172名(9.56%)和1628名(90.44%)慢性阻塞性肺病患者和非慢性阻塞性肺病患者接受了TEVAR治疗。慢性阻塞性肺病患者的合并症负担较重。经过倾向分数匹配后,所有 172 名慢性阻塞性肺病患者与 440 名非慢性阻塞性肺病患者进行了匹配。慢性阻塞性肺病患者和非慢性阻塞性肺病患者的死亡率相当(10.12% vs 6.82%,P = .18)。但是,慢性阻塞性肺病患者发生肺部并发症的风险更高(20.83% vs 13.18%,p = .02)。两组患者 30 天内的其他结果相似:结论:慢性阻塞性肺病患者的肺部并发症发生率比非慢性阻塞性肺病患者高出 58.04%,而 30 天内的其他结果与非慢性阻塞性肺病患者相当。因此,TBAD TEVAR术后密切监测并及时干预慢性阻塞性肺病患者的肺部并发症非常重要。未来的研究应调查这些慢性阻塞性肺病患者的长期预后。
{"title":"Thirty-day outcomes of endovascular repair of Stanford type B aortic dissection in patients with chronic obstructive pulmonary disease.","authors":"Renxi Li, Anton Sidawy, Bao-Ngoc Nguyen","doi":"10.1177/17085381241298732","DOIUrl":"https://doi.org/10.1177/17085381241298732","url":null,"abstract":"<p><strong>Background: </strong>Thoracic Endovascular Aortic Repair (TEVAR) has revolutionized the surgical treatment for Stanford type B aortic dissection (TBAD). While chronic obstructive pulmonary disease (COPD) is associated with worse outcomes in major surgeries, the specific outcomes of TEVAR in patients with COPD have not been extensively explored. This study aimed to evaluate the 30-day postoperative outcomes of COPD patients undergoing TEVAR for TBAD utilizing data from a multi-institutional national registry.</p><p><strong>Methods: </strong>Patients who underwent TEVAR for TBAD were identified in the ACS-NSQIP database from 2005 to 2022. A 1:3 propensity-score matching was used to match demographics and preoperative characteristics between patients with and without COPD. Thirty-day postoperative outcomes were compared.</p><p><strong>Results: </strong>There were 172 (9.56%) and 1628 (90.44%) COPD and non-COPD patients who underwent TEVAR for TBAD, respectively. Patients with COPD had a higher comorbidity burden. After the propensity-score matching, all 172 COPD patients were matched to 440 non-COPD patients. COPD and non-COPD patients had comparable mortality rates (10.12% vs 6.82%, <i>p</i> = .18). However, COPD patients had a higher risk of pulmonary complications (20.83% vs 13.18%, <i>p</i> = .02). All other 30-day outcomes were similar between the two groups.</p><p><strong>Conclusion: </strong>COPD patients had 58.04% higher pulmonary complications while all other 30-day outcomes were comparable to their non-COPD counterparts. Therefore, close monitoring and timely intervention for pulmonary complications in COPD patients can be important after TEVAR for TBAD. Future studies should investigate long-term outcomes among these COPD patients.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381241298732"},"PeriodicalIF":1.0,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142584414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5-years patency results of Zilver PTX on the femoro-popliteal arterial segment: A Northern Sydney experience. 股-腘动脉段 Zilver PTX 5 年通畅效果:北悉尼经验。
IF 1 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-11-02 DOI: 10.1177/17085381241297765
Erin C Saricilar, Naomi Anning, Raleene Gatmaitan, Kiraati Patel, Charles Fisher, Vikram Puttaswamy

Background: The burden of peripheral arterial disease is increasing. Treatment of femoro-popliteal lesions remains challenging despite novel endovascular devices. Drug-eluting stents suppress post-treatment inflammation and reducing neo-intimal hyperplasia to reduce in-stent restenosis.

Methods: A multi-centre retrospective 5-years longitudinal study was undertaken to evaluate freedom from clinically driven target limb revascularisation (FF CD-TLR) and patency of Zilver PTX stents in treating symptomatic femoro-popliteal stenotic lesions. Kaplan-Meier survival curves were used to demonstrate FF CD-TLR, primary, primary assisted and secondary patency.

Results: There were 148 patients and 183 lesions treated with a mean age of 80.3 years and 52% males. The all-cause 5-years mortality was 25%. FF CD-TLR yearly patencies to 5 years were 81%, 67%, 62%, 57% and 52%, respectively, with significantly poorer outcomes for in-stent restenosis, longer stent lengths and lesions at the femoro-popliteal junction. Primary patencies were 63%, 47%, 40%, 34% and 24%, assisted primary patencies were 90%, 75%, 68%, 59% and 48% and secondary patencies were 96%, 94%, 94%, 92% and 92%. Major adverse limb events were 5% at 1-year and cumulative at 5-years was 16%.

Discussion: The clinical outcomes in this study population are comparable to recent publications with smaller cohorts. Our study confirms Zilver PTX has very good primary patency over 5 years with no discernible effect on all-cause mortality in an elderly cohort with particularly long treated lesions. Our results are similar to those seen in younger patients with shorter lesions. Nonetheless, longer lesions required more reinterventions to maintain patency.

Conclusion: Zilver PTX is a safe and durable drug-eluting stent when utilised in the management of femoro-popliteal stenotic lesions with good long-term patency and limited need for re-intervention.

背景:外周动脉疾病的负担日益加重。尽管有新型的血管内设备,但股骨腘动脉病变的治疗仍具有挑战性。药物洗脱支架可抑制治疗后炎症,减少新内膜增生,从而减少支架内再狭窄:我们开展了一项为期5年的多中心回顾性纵向研究,评估Zilver PTX支架在治疗无症状股腘动脉狭窄病变时的临床驱动靶肢血运重建(FF CD-TLR)自由度和通畅性。Kaplan-Meier 生存曲线用于显示 FF CD-TLR、主要通畅率、主要辅助通畅率和次要通畅率:共有 148 名患者和 183 个病灶接受了治疗,平均年龄为 80.3 岁,男性占 52%。5年全因死亡率为25%。FF CD-TLR 5年的年通畅率分别为81%、67%、62%、57%和52%,支架内再狭窄、支架长度较长和股腘交界处病变的治疗效果明显较差。原发性通畅率分别为63%、47%、40%、34%和24%,辅助性原发性通畅率分别为90%、75%、68%、59%和48%,继发性通畅率分别为96%、94%、94%、92%和92%。1年内肢体主要不良事件为5%,5年累计不良事件为16%:讨论:本研究人群的临床结果与近期发表的较小群体的研究结果相当。我们的研究证实,Zilver PTX 在 5 年内具有非常好的原发性通畅性,对治疗病变时间特别长的老年人群的全因死亡率没有明显影响。我们的结果与病变较短的年轻患者的结果相似。然而,较长的病变需要更多的再干预才能维持通畅:结论:Zilver PTX 是一种安全耐用的药物洗脱支架,可用于股腘动脉狭窄病变的治疗,具有良好的长期通畅性和有限的再介入需求。
{"title":"5-years patency results of Zilver PTX on the femoro-popliteal arterial segment: A Northern Sydney experience.","authors":"Erin C Saricilar, Naomi Anning, Raleene Gatmaitan, Kiraati Patel, Charles Fisher, Vikram Puttaswamy","doi":"10.1177/17085381241297765","DOIUrl":"https://doi.org/10.1177/17085381241297765","url":null,"abstract":"<p><strong>Background: </strong>The burden of peripheral arterial disease is increasing. Treatment of femoro-popliteal lesions remains challenging despite novel endovascular devices. Drug-eluting stents suppress post-treatment inflammation and reducing neo-intimal hyperplasia to reduce in-stent restenosis.</p><p><strong>Methods: </strong>A multi-centre retrospective 5-years longitudinal study was undertaken to evaluate freedom from clinically driven target limb revascularisation (FF CD-TLR) and patency of Zilver PTX stents in treating symptomatic femoro-popliteal stenotic lesions. Kaplan-Meier survival curves were used to demonstrate FF CD-TLR, primary, primary assisted and secondary patency.</p><p><strong>Results: </strong>There were 148 patients and 183 lesions treated with a mean age of 80.3 years and 52% males. The all-cause 5-years mortality was 25%. FF CD-TLR yearly patencies to 5 years were 81%, 67%, 62%, 57% and 52%, respectively, with significantly poorer outcomes for in-stent restenosis, longer stent lengths and lesions at the femoro-popliteal junction. Primary patencies were 63%, 47%, 40%, 34% and 24%, assisted primary patencies were 90%, 75%, 68%, 59% and 48% and secondary patencies were 96%, 94%, 94%, 92% and 92%. Major adverse limb events were 5% at 1-year and cumulative at 5-years was 16%.</p><p><strong>Discussion: </strong>The clinical outcomes in this study population are comparable to recent publications with smaller cohorts. Our study confirms Zilver PTX has very good primary patency over 5 years with no discernible effect on all-cause mortality in an elderly cohort with particularly long treated lesions. Our results are similar to those seen in younger patients with shorter lesions. Nonetheless, longer lesions required more reinterventions to maintain patency.</p><p><strong>Conclusion: </strong>Zilver PTX is a safe and durable drug-eluting stent when utilised in the management of femoro-popliteal stenotic lesions with good long-term patency and limited need for re-intervention.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381241297765"},"PeriodicalIF":1.0,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142564897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term results of carotid body tumours surgery and predictive analytics on metastatic disease and recurrence. 颈动脉体肿瘤手术的长期效果以及对转移性疾病和复发的预测分析。
IF 1 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-11-01 DOI: 10.1177/17085381241297067
Najibullah I Verdikhanov, Andrey V Chupin, Irina E Timina, Zaurbek A Adyrkhaev
<p><strong>Objective: </strong>The determination of clinico-surgical predictors of carotid body tumour (CBT) metastasizing and/or recurrence.</p><p><strong>Methods: </strong>Patients with CBT but without a history of its previous treatment who had received inpatient medical aid at a tertiary surgical centre during the period 2011-2021 were retrospectively reviewed to obtain baseline data. Primary endpoints of the study were CBT metastasizing and/or local recurrence after radical surgery (composite endpoint) and overall survival. Secondary endpoint of the study was primary patency of carotid arteries that had been repaired/reconstructed as a result of CBT removal. Suspected predictors of CBT metastasizing/recurrence were young age of CBT onset, positive family history, multifocal paraganglioma, Shamblin type III CBT, carotid bifurcation and/or internal carotid artery (ICA) reconstruction as a result of CBT excision. To detect CBT metastasizing/recurrence, prospective imaging-based whole-body screening was suggested to patients.</p><p><strong>Results: </strong>Fifty-three patients met the eligibility criteria. The overall survival rate was 100% at a median follow-up time of 68 months (interquartile range [IQR] 27‒104.5 months). The primary patency of repaired carotid arteries (<i>n</i> = 9) was 88.9% at a median follow-up time of 99 months (IQR 15.5‒116.5 months). Thirty-nine patients underwent the prospective whole-body screening. Eight (20.5%) patients were diagnosed with metastatic disease (<i>n</i> = 6) or local recurrence (<i>n</i> = 2). Patients with CBT metastasizing/recurrence were younger at age of CBT onset (<i>p</i> = .011), more frequently had Shamblin type III CBT (<i>p</i> = .004) and the necessity for carotid artery repair/reconstruction (<i>p</i> = .041) than patients without metastasizing/recurrence. These two groups were similar in terms of gender (<i>p</i> = .682), the prevalence of multifocal paraganglioma (<i>p</i> = .167) and positive family history (<i>p</i> = .180). Only the belonging of a CBT to Shamblin type III was defined as a statistically significant predictor of CBT metastasizing/recurrence in both univariable and multivariable binary logistic regression analyses (odds ratio 30; 95% confidence interval: 2.649-339.739; <i>p</i> = .006 and odds ratio 75.409; 95% confidence interval: 1.082-5254.557; <i>p</i> = .046, respectively). Multifocal paraganglioma as a predictor exhibited a strong tendency towards statistical significance (<i>p</i> = .09 and <i>p</i> = .072, respectively). Other suspected predictors didn't reach the level of statistical significance either in univariable (<i>p</i> = .151 for positive family history) or in multivariable (<i>p</i> = .211 for age of CBT onset; <i>p</i> = .734 for carotid artery reconstruction/repair) binary logistic regression analyses.</p><p><strong>Conclusion: </strong>Shamblin type III CBT has high potential for metastasizing and recurrence. Patients with Shamblin type III CBT an
目的:确定颈动脉体肿瘤(CBT)转移和/或复发的临床手术预测因素:确定颈动脉体肿瘤(CBT)转移和/或复发的临床手术预测因素:对 2011-2021 年期间在一家三级外科中心接受住院医疗救助的 CBT 患者进行回顾性研究,以获得基线数据。研究的主要终点是CBT转移和/或根治术后局部复发(复合终点)和总生存期。研究的次要终点是因CBT切除而修复/重建的颈动脉的主要通畅性。CBT转移/复发的可疑预测因素包括:CBT发病年龄小、阳性家族史、多灶性副神经节瘤、Shamblin III型CBT、CBT切除后颈动脉分叉和/或颈内动脉(ICA)重建。为检测CBT转移/复发,建议患者进行基于影像学的前瞻性全身筛查:结果:53 名患者符合资格标准。中位随访时间为 68 个月(四分位间距 [IQR] 27-104.5 个月),总生存率为 100%。中位随访时间为 99 个月(IQR 15.5-116.5 个月),修复后颈动脉(9 例)的初次通畅率为 88.9%。39 名患者接受了前瞻性全身筛查。8例(20.5%)患者被诊断为转移性疾病(6例)或局部复发(2例)。与没有转移/复发的患者相比,CBT 转移/复发患者的发病年龄更小(p = .011),更经常出现 Shamblin III 型 CBT(p = .004)和颈动脉修复/重建的必要性(p = .041)。这两组患者在性别(p = .682)、多灶性副神经管瘤患病率(p = .167)和阳性家族史(p = .180)方面相似。在单变量和多变量二元逻辑回归分析中,只有属于 Shamblin III 型的 CBT 被定义为具有统计学意义的 CBT 转移/复发预测因子(分别为几率比 30;95% 置信区间:2.649-339.739;p = .006 和几率比 75.409;95% 置信区间:1.082-5254.557;p = .046)。多灶性副神经节瘤作为一种预测因子,显示出较强的统计显著性趋势(分别为 p = .09 和 p = .072)。在单变量(阳性家族史的 p = .151)或多变量(CBT 发病年龄的 p = .211;颈动脉重建/修复的 p = .734)二元逻辑回归分析中,其他可疑预测因子均未达到统计学意义水平:结论:Shamblin III 型 CBT 转移和复发的可能性很大。结论:Shamblin III 型 CBT 和/或多灶性副神经节瘤患者应考虑进行基因检测以及术前全身放射成像和术后长期全身成像随访。
{"title":"Long-term results of carotid body tumours surgery and predictive analytics on metastatic disease and recurrence.","authors":"Najibullah I Verdikhanov, Andrey V Chupin, Irina E Timina, Zaurbek A Adyrkhaev","doi":"10.1177/17085381241297067","DOIUrl":"https://doi.org/10.1177/17085381241297067","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;The determination of clinico-surgical predictors of carotid body tumour (CBT) metastasizing and/or recurrence.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Patients with CBT but without a history of its previous treatment who had received inpatient medical aid at a tertiary surgical centre during the period 2011-2021 were retrospectively reviewed to obtain baseline data. Primary endpoints of the study were CBT metastasizing and/or local recurrence after radical surgery (composite endpoint) and overall survival. Secondary endpoint of the study was primary patency of carotid arteries that had been repaired/reconstructed as a result of CBT removal. Suspected predictors of CBT metastasizing/recurrence were young age of CBT onset, positive family history, multifocal paraganglioma, Shamblin type III CBT, carotid bifurcation and/or internal carotid artery (ICA) reconstruction as a result of CBT excision. To detect CBT metastasizing/recurrence, prospective imaging-based whole-body screening was suggested to patients.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Fifty-three patients met the eligibility criteria. The overall survival rate was 100% at a median follow-up time of 68 months (interquartile range [IQR] 27‒104.5 months). The primary patency of repaired carotid arteries (&lt;i&gt;n&lt;/i&gt; = 9) was 88.9% at a median follow-up time of 99 months (IQR 15.5‒116.5 months). Thirty-nine patients underwent the prospective whole-body screening. Eight (20.5%) patients were diagnosed with metastatic disease (&lt;i&gt;n&lt;/i&gt; = 6) or local recurrence (&lt;i&gt;n&lt;/i&gt; = 2). Patients with CBT metastasizing/recurrence were younger at age of CBT onset (&lt;i&gt;p&lt;/i&gt; = .011), more frequently had Shamblin type III CBT (&lt;i&gt;p&lt;/i&gt; = .004) and the necessity for carotid artery repair/reconstruction (&lt;i&gt;p&lt;/i&gt; = .041) than patients without metastasizing/recurrence. These two groups were similar in terms of gender (&lt;i&gt;p&lt;/i&gt; = .682), the prevalence of multifocal paraganglioma (&lt;i&gt;p&lt;/i&gt; = .167) and positive family history (&lt;i&gt;p&lt;/i&gt; = .180). Only the belonging of a CBT to Shamblin type III was defined as a statistically significant predictor of CBT metastasizing/recurrence in both univariable and multivariable binary logistic regression analyses (odds ratio 30; 95% confidence interval: 2.649-339.739; &lt;i&gt;p&lt;/i&gt; = .006 and odds ratio 75.409; 95% confidence interval: 1.082-5254.557; &lt;i&gt;p&lt;/i&gt; = .046, respectively). Multifocal paraganglioma as a predictor exhibited a strong tendency towards statistical significance (&lt;i&gt;p&lt;/i&gt; = .09 and &lt;i&gt;p&lt;/i&gt; = .072, respectively). Other suspected predictors didn't reach the level of statistical significance either in univariable (&lt;i&gt;p&lt;/i&gt; = .151 for positive family history) or in multivariable (&lt;i&gt;p&lt;/i&gt; = .211 for age of CBT onset; &lt;i&gt;p&lt;/i&gt; = .734 for carotid artery reconstruction/repair) binary logistic regression analyses.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Shamblin type III CBT has high potential for metastasizing and recurrence. Patients with Shamblin type III CBT an","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381241297067"},"PeriodicalIF":1.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142564903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative analysis of negative pressure wound therapy (PICO) and standard dressing application after arterial vascular reconstructions. 动脉血管重建后负压伤口疗法(PICO)与标准敷料应用的比较分析。
IF 1 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-10-26 DOI: 10.1177/17085381241296606
Valentyna Kostiuk, Soraya Fereydooni, Ocean Setia, Sarah A Loh, David Strosberg, Britt H Tonnessen, Cassius Iyad Ochoa Chaar, Edouard Aboian

Introduction: Surgical site infections following arterial reconstructions with femoral exposures are common and potentially preventable. Negative pressure wound therapy has emerged as a potential solution to minimize groin wound complications. Our study evaluates efficacy of a negative pressure therapy (PICO dressing) in reducing groin wound complications after vascular reconstructions.

Methods: A retrospective single center comparative analysis of vascular reconstructions involving common femoral artery dissection was performed between July 2021 and June 2023. Patients were divided into two groups: patients treated with PICO device and patients who received standard dressing (non-PICO). Patient demographics, comorbidities, vascular evaluation, and procedure indications were compared. Previous interventions, incision orientation and procedure types were noted. The wound complication categories were graded according to the Szilagyi classification: grade 1 (superficial infection/minor dehiscence), grade 2 (deep infection/major dehiscence), and grade 3 (artery or prosthetic involvement). Statistical significance level was determined at p < .05 for all analyses.

Results: A total of 217 groin dissections in 184 patients were analyzed with 132 and 85 groin dissections in the PICO and non-PICO groups, respectively. The baseline characteristics were similar between the groups in terms of age, sex, BMI, and procedure indications. Prior endovascular procedures and re-operative groin surgeries were more prevalent in the PICO group. The use of antibiotics post-operatively for groin wound complication was greater in the non-PICO group. The incidence of wound complications was higher in the non-PICO group (29.4% vs 10.6%, p < .001). Multivariate logistic regression analysis determined that PICO dressing as well as hybrid and endovascular index procedures were associated with lower risks of groin complications.

Conclusion: PICO dressing decreased the incidence of groin wound complications in patients undergoing open vascular reconstructions. This study highlights the value of adjunctive negative pressure therapy in reduction of wound complications after arterial reconstructions in the inguinal region.

导言:股外露动脉重建术后的手术部位感染很常见,而且可能是可以预防的。负压伤口疗法已成为减少腹股沟伤口并发症的潜在解决方案。我们的研究评估了负压疗法(PICO 敷料)在减少血管重建术后腹股沟伤口并发症方面的疗效:方法:我们在 2021 年 7 月至 2023 年 6 月期间对涉及股总动脉夹层的血管重建进行了回顾性单中心比较分析。患者分为两组:使用 PICO 装置治疗的患者和使用标准敷料(非 PICO)治疗的患者。比较了患者的人口统计学特征、合并症、血管评估和手术适应症。同时还记录了之前的干预措施、切口方向和手术类型。根据 Szilagyi 分类法对伤口并发症进行了分级:1 级(浅表感染/轻度开裂)、2 级(深度感染/严重开裂)和 3 级(动脉或假体受累)。所有分析的统计学意义均以 p < .05 为标准:共对 184 名患者的 217 例腹股沟撕裂进行了分析,其中 PICO 组和非 PICO 组分别有 132 例和 85 例腹股沟撕裂。两组患者在年龄、性别、体重指数和手术适应症方面的基线特征相似。在 PICO 组中,既往接受过血管内手术和腹股沟再次手术的比例更高。非 PICO 组术后因腹股沟伤口并发症使用抗生素的比例更高。非 PICO 组的伤口并发症发生率更高(29.4% vs 10.6%,p < .001)。多变量逻辑回归分析表明,PICO敷料以及杂交和血管内指数手术与较低的腹股沟并发症风险相关:结论:PICO 敷料降低了开放血管重建患者腹股沟伤口并发症的发生率。这项研究强调了辅助负压疗法在减少腹股沟区域动脉重建术后伤口并发症方面的价值。
{"title":"Comparative analysis of negative pressure wound therapy (PICO) and standard dressing application after arterial vascular reconstructions.","authors":"Valentyna Kostiuk, Soraya Fereydooni, Ocean Setia, Sarah A Loh, David Strosberg, Britt H Tonnessen, Cassius Iyad Ochoa Chaar, Edouard Aboian","doi":"10.1177/17085381241296606","DOIUrl":"https://doi.org/10.1177/17085381241296606","url":null,"abstract":"<p><strong>Introduction: </strong>Surgical site infections following arterial reconstructions with femoral exposures are common and potentially preventable. Negative pressure wound therapy has emerged as a potential solution to minimize groin wound complications. Our study evaluates efficacy of a negative pressure therapy (PICO dressing) in reducing groin wound complications after vascular reconstructions.</p><p><strong>Methods: </strong>A retrospective single center comparative analysis of vascular reconstructions involving common femoral artery dissection was performed between July 2021 and June 2023. Patients were divided into two groups: patients treated with PICO device and patients who received standard dressing (non-PICO). Patient demographics, comorbidities, vascular evaluation, and procedure indications were compared. Previous interventions, incision orientation and procedure types were noted. The wound complication categories were graded according to the Szilagyi classification: grade 1 (superficial infection/minor dehiscence), grade 2 (deep infection/major dehiscence), and grade 3 (artery or prosthetic involvement). Statistical significance level was determined at <i>p</i> < .05 for all analyses.</p><p><strong>Results: </strong>A total of 217 groin dissections in 184 patients were analyzed with 132 and 85 groin dissections in the PICO and non-PICO groups, respectively. The baseline characteristics were similar between the groups in terms of age, sex, BMI, and procedure indications. Prior endovascular procedures and re-operative groin surgeries were more prevalent in the PICO group. The use of antibiotics post-operatively for groin wound complication was greater in the non-PICO group. The incidence of wound complications was higher in the non-PICO group (29.4% vs 10.6%, <i>p</i> < .001). Multivariate logistic regression analysis determined that PICO dressing as well as hybrid and endovascular index procedures were associated with lower risks of groin complications.</p><p><strong>Conclusion: </strong>PICO dressing decreased the incidence of groin wound complications in patients undergoing open vascular reconstructions. This study highlights the value of adjunctive negative pressure therapy in reduction of wound complications after arterial reconstructions in the inguinal region.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381241296606"},"PeriodicalIF":1.0,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142508964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracranial internal carotid artery aneurysm: Surgical approach to a rare entity. 颅外颈内动脉瘤:罕见病例的手术方法。
IF 1 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-10-13 DOI: 10.1177/17085381241290634
Didem Melis Oztas, Seckin Cobanoglu, Asli Cakir, Okan Kuguoglu, Emre Oteyaka, Murat Ugurlucan

Background: Extracranial internal carotid artery aneurysms are rare entities that arise within the carotid triangle. Although rare, they are clinically significant due to the risk of neurologic thromboembolic events, compression of cranial nerves and vasculature, rupture, and ischemia.

Objective: Surgery is the gold-standard treatment for symptomatic patients of all ages with extracranial internal carotid artery aneurysm.

Method: A 26-year-old female patient was admitted to our institution with complaints of left auricular pain, hoarseness, and uncontrollable hypertension. She had a pulsatile mass located at the left cervical region. After diagnosing the extracranial internal carotid artery aneurysm, it was decided that surgery was necessary to relieve the patient's discomfort and prevent possible complications from the aneurysm in the left carotid artery.

Result: In the operation, the aneurysmatic segment was resected and sent for histopathological evaluation. Saphenous vein graft was interposed as end to end anastomosis to the proximal and distal healthy segments of the internal carotid artery.

Conclusion: This case report highlights the surgical management of a 26-year-old female patient who presented to our institution with complaints of left auricular pain, hoarseness, uncontrolled hypertension, and a pulsatile mass localized at the left cervical region and diagnosed extracranial internal carotid artery aneurysm.

背景:颅外颈内动脉瘤是发生在颈动脉三角内的罕见实体。虽然罕见,但由于存在神经系统血栓栓塞事件、压迫颅神经和血管、破裂和缺血的风险,因此具有重要的临床意义:手术是治疗有症状的各年龄段颅外颈内动脉瘤患者的金标准:一名 26 岁的女性患者因主诉左耳疼痛、声音嘶哑和无法控制的高血压而入住我院。她的左颈部有一个搏动性肿块。在诊断出颅内颈内动脉瘤后,医生决定必须进行手术治疗,以缓解患者的不适症状,并防止左侧颈内动脉瘤可能引发的并发症:手术切除了动脉瘤部分,并送去进行组织病理学评估。结果:手术中,动脉瘤部分被切除,并送去进行组织病理学评估,无隐静脉移植作为端对端吻合器与颈内动脉的近端和远端健康部分相连:本病例报告重点介绍了一名 26 岁女性患者的手术治疗情况,该患者因主诉左耳疼痛、声音嘶哑、高血压未得到控制、左颈部局部有搏动性肿块而到我院就诊,诊断为颅外颈内动脉瘤。
{"title":"Extracranial internal carotid artery aneurysm: Surgical approach to a rare entity.","authors":"Didem Melis Oztas, Seckin Cobanoglu, Asli Cakir, Okan Kuguoglu, Emre Oteyaka, Murat Ugurlucan","doi":"10.1177/17085381241290634","DOIUrl":"https://doi.org/10.1177/17085381241290634","url":null,"abstract":"<p><strong>Background: </strong>Extracranial internal carotid artery aneurysms are rare entities that arise within the carotid triangle. Although rare, they are clinically significant due to the risk of neurologic thromboembolic events, compression of cranial nerves and vasculature, rupture, and ischemia.</p><p><strong>Objective: </strong>Surgery is the gold-standard treatment for symptomatic patients of all ages with extracranial internal carotid artery aneurysm.</p><p><strong>Method: </strong>A 26-year-old female patient was admitted to our institution with complaints of left auricular pain, hoarseness, and uncontrollable hypertension. She had a pulsatile mass located at the left cervical region. After diagnosing the extracranial internal carotid artery aneurysm, it was decided that surgery was necessary to relieve the patient's discomfort and prevent possible complications from the aneurysm in the left carotid artery.</p><p><strong>Result: </strong>In the operation, the aneurysmatic segment was resected and sent for histopathological evaluation. Saphenous vein graft was interposed as end to end anastomosis to the proximal and distal healthy segments of the internal carotid artery.</p><p><strong>Conclusion: </strong>This case report highlights the surgical management of a 26-year-old female patient who presented to our institution with complaints of left auricular pain, hoarseness, uncontrolled hypertension, and a pulsatile mass localized at the left cervical region and diagnosed extracranial internal carotid artery aneurysm.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381241290634"},"PeriodicalIF":1.0,"publicationDate":"2024-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142475962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing anticoagulant therapy alone, anticoagulant therapy in combination with catheter-directed thrombolysis, and anticoagulant therapy in combination with pharmacomechanical catheter-directed thrombolysis in the patients with optional inferior vena cava filter-related thrombosis: A single-center retrospective study. 在可选的下腔静脉滤器相关血栓形成患者中,比较单纯抗凝疗法、抗凝疗法与导管引导溶栓相结合,以及抗凝疗法与药物机械导管引导溶栓相结合:单中心回顾性研究
IF 1 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-10-12 DOI: 10.1177/17085381241289825
Zhaoyang Li, Zhicheng Duan, Huitang Yang, Meng Li, Yandong Cai, Zhan Jiang, Guoju Fan, Kaiqiang Wang, Bo Chen, Hongwei Zhang, Yankui Li
<p><strong>Objective: </strong>To analyze the treatment methods and efficacy of inferior vena cava filter thrombosis (IVCFT).</p><p><strong>Materials and methods: </strong>In this retrospective study, the clinical data for 47 patients with IVCFT who underwent sequential treatment at the Department of Vascular Surgery, Tianjin Medical University Second Hospital, from January 2020 to January 2023 were analyzed. Patients were divided into three groups according to the treatment method: anticoagulant therapy (AC group), anticoagulation plus catheter-directed thrombolysis (CDT group), and anticoagulation plus AngioJet thrombectomy plus catheter-directed thrombolysis (PCDT group). The evaluation criteria for efficacy mainly included preoperative and postoperative clinical symptoms (Villalta score), thrombus diameter, thrombus clearance rate, filter retrieval rate, filter retention time, and urokinase dosage.</p><p><strong>Results: </strong>This study included 47 patients, of whom 31 were males (65.9%) and 16 females (34.1%), with a mean age of 72.05 ± 8.32 years. An Aegisy filter was used in seven patients, whereas an Illicium filter was used in forty patients. There were a total of nineteen patients in the anticoagulation-only group, with complete dissolution of the intraluminal thrombus in five patients, a residual thrombus with a maximum diameter ≤1 cm in three patients, and a residual thrombus with a maximum diameter >1 cm in eleven patients. The Villalta score was 7.16 ± 0.6 before treatment and decreased to 3.79 ± 0.59 after treatment. The thrombus diameter decreased from an average of 1.46 ± 0.2 cm before treatment to an average of 0.85 ± 0.14 cm after treatment. The retrieval rate for the filters was 42.11% (8/19), with an average dwell time of 27.4 ± 1.3 days for the filters. The CDT group consisted of 17 patients. Among whom we observed, complete dissolution of the intraluminal thrombus was observed in six patients, residual thrombus with a maximum diameter ≤1 cm in nine patients, and residual thrombus with a maximum diameter >1 cm in two patients. The Villalta score decreased from 7.53 ± 0.83 before treatment to 2.06 ± 0.39 after treatment. The thrombus diameter also decreased from 1.46 ± 0.16 cm before treatment to 0.35 ± 0.11 cm after treatment. The retrieval rate of the filters was 88.24% (15/17), and the average filter indwelling time was 19.25 ± 4.5 days. The PCDT group consisted of 11 patients. We observed complete dissolution of the intraluminal thrombus in four patients, residual thrombus with a maximum diameter ≤1 cm in six patients, and residual thrombus with a maximum diameter >1 cm in one patient. The Villalta score decreased from 7.45 ± 0.76 before treatment to 2.09 ± 0.55 after treatment. The thrombus diameter decreased from 1.50 ± 0.21 cm before treatment to 0.33 ± 0.35 cm after treatment, and the rate of filter retrieval was 90.91% (10/11).</p><p><strong>Conclusion: </strong>The three treatments of anticoagulation therapy, CD
目的:分析下腔静脉滤器血栓形成的治疗方法和疗效:分析下腔静脉滤器血栓(IVCFT)的治疗方法和疗效:本回顾性研究分析了2020年1月至2023年1月在天津医科大学第二医院血管外科接受序贯治疗的47例IVCFT患者的临床资料。根据治疗方法将患者分为三组:抗凝治疗组(AC 组)、抗凝加导管引导溶栓治疗组(CDT 组)和抗凝加 AngioJet 取栓加导管引导溶栓治疗组(PCDT 组)。疗效评估标准主要包括术前和术后临床症状(Villalta评分)、血栓直径、血栓清除率、滤器取栓率、滤器保留时间和尿激酶用量:本研究共纳入 47 例患者,其中男性 31 例(65.9%),女性 16 例(34.1%),平均年龄(72.05±8.32)岁。七名患者使用了 Aegisy 过滤器,四十名患者使用了 Illicium 过滤器。单纯抗凝组共有 19 名患者,其中 5 名患者的腔内血栓完全溶解,3 名患者的残余血栓最大直径≤1 厘米,11 名患者的残余血栓最大直径大于 1 厘米。治疗前的 Villalta 评分为 7.16 ± 0.6,治疗后降至 3.79 ± 0.59。血栓直径从治疗前的平均 1.46 ± 0.2 厘米降至治疗后的平均 0.85 ± 0.14 厘米。滤器取回率为 42.11%(8/19),滤器平均停留时间为 27.4 ± 1.3 天。CDT 组有 17 名患者。我们观察到,其中 6 名患者的腔内血栓完全溶解,9 名患者的残余血栓最大直径≤1 厘米,2 名患者的残余血栓最大直径大于 1 厘米。Villalta 评分从治疗前的 7.53 ± 0.83 降至治疗后的 2.06 ± 0.39。血栓直径也从治疗前的 1.46 ± 0.16 厘米降至治疗后的 0.35 ± 0.11 厘米。滤器取回率为 88.24%(15/17),滤器平均留置时间为 19.25 ± 4.5 天。PCDT 组有 11 名患者。我们观察到 4 名患者的腔内血栓完全溶解,6 名患者的残余血栓最大直径≤1 厘米,1 名患者的残余血栓最大直径大于 1 厘米。Villalta 评分从治疗前的 7.45 ± 0.76 降至治疗后的 2.09 ± 0.55。血栓直径从治疗前的 1.50 ± 0.21 厘米降至治疗后的 0.33 ± 0.35 厘米,滤器取出率为 90.91%(10/11):结论:抗凝治疗、CDT和PCDT三种治疗方法对IVCFT患者术前和术后溶栓及症状改善均有意义。CDT 和 PCDT 的应用优于抗凝疗法,而 CDT 组和 PCDT 组之间无明显差异。抗凝治疗组的滤器取回率最低,CDT 组和 PCDT 组之间无明显差异。
{"title":"Comparing anticoagulant therapy alone, anticoagulant therapy in combination with catheter-directed thrombolysis, and anticoagulant therapy in combination with pharmacomechanical catheter-directed thrombolysis in the patients with optional inferior vena cava filter-related thrombosis: A single-center retrospective study.","authors":"Zhaoyang Li, Zhicheng Duan, Huitang Yang, Meng Li, Yandong Cai, Zhan Jiang, Guoju Fan, Kaiqiang Wang, Bo Chen, Hongwei Zhang, Yankui Li","doi":"10.1177/17085381241289825","DOIUrl":"10.1177/17085381241289825","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To analyze the treatment methods and efficacy of inferior vena cava filter thrombosis (IVCFT).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;In this retrospective study, the clinical data for 47 patients with IVCFT who underwent sequential treatment at the Department of Vascular Surgery, Tianjin Medical University Second Hospital, from January 2020 to January 2023 were analyzed. Patients were divided into three groups according to the treatment method: anticoagulant therapy (AC group), anticoagulation plus catheter-directed thrombolysis (CDT group), and anticoagulation plus AngioJet thrombectomy plus catheter-directed thrombolysis (PCDT group). The evaluation criteria for efficacy mainly included preoperative and postoperative clinical symptoms (Villalta score), thrombus diameter, thrombus clearance rate, filter retrieval rate, filter retention time, and urokinase dosage.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;This study included 47 patients, of whom 31 were males (65.9%) and 16 females (34.1%), with a mean age of 72.05 ± 8.32 years. An Aegisy filter was used in seven patients, whereas an Illicium filter was used in forty patients. There were a total of nineteen patients in the anticoagulation-only group, with complete dissolution of the intraluminal thrombus in five patients, a residual thrombus with a maximum diameter ≤1 cm in three patients, and a residual thrombus with a maximum diameter &gt;1 cm in eleven patients. The Villalta score was 7.16 ± 0.6 before treatment and decreased to 3.79 ± 0.59 after treatment. The thrombus diameter decreased from an average of 1.46 ± 0.2 cm before treatment to an average of 0.85 ± 0.14 cm after treatment. The retrieval rate for the filters was 42.11% (8/19), with an average dwell time of 27.4 ± 1.3 days for the filters. The CDT group consisted of 17 patients. Among whom we observed, complete dissolution of the intraluminal thrombus was observed in six patients, residual thrombus with a maximum diameter ≤1 cm in nine patients, and residual thrombus with a maximum diameter &gt;1 cm in two patients. The Villalta score decreased from 7.53 ± 0.83 before treatment to 2.06 ± 0.39 after treatment. The thrombus diameter also decreased from 1.46 ± 0.16 cm before treatment to 0.35 ± 0.11 cm after treatment. The retrieval rate of the filters was 88.24% (15/17), and the average filter indwelling time was 19.25 ± 4.5 days. The PCDT group consisted of 11 patients. We observed complete dissolution of the intraluminal thrombus in four patients, residual thrombus with a maximum diameter ≤1 cm in six patients, and residual thrombus with a maximum diameter &gt;1 cm in one patient. The Villalta score decreased from 7.45 ± 0.76 before treatment to 2.09 ± 0.55 after treatment. The thrombus diameter decreased from 1.50 ± 0.21 cm before treatment to 0.33 ± 0.35 cm after treatment, and the rate of filter retrieval was 90.91% (10/11).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The three treatments of anticoagulation therapy, CD","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381241289825"},"PeriodicalIF":1.0,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142475961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative outcomes of surgical and conservative management in carotid artery dissection. 颈动脉夹层手术与保守治疗的疗效比较。
IF 1 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-10-05 DOI: 10.1177/17085381241289815
Yuyao Feng, Zhan Zhu, Jiang Shao, Kang Li, Yiyun Xie, Lizhi Xie, Yuru Wang, Lin Wang, Huanyu Dai, Zhichao Lai, Bao Liu

Objectives: Carotid artery dissection (CAD) is a significant cause of strokes in young individuals, leading to severe complications and socioeconomic burdens. Despite antithrombotic therapy being the primary management strategy, optimal treatment for patients with recurrent or worsening symptoms remains undefined. This study aims to describe the characteristics and evaluate the outcomes of conservative versus surgical management in CAD patients.

Methods: A total of 23 patients presenting with CAD from November 2014 to December 2021 were reviewed retrospectively. Patient demographics, vascular risk factors, symptoms, imaging results, treatment details, and follow-up information were collected and analyzed. Propensity score matching (PSM) was utilized to enhance comparability.

Results: The mean age of the patients was 46.4 ± 9.4 years, with a median follow-up of 12 (range 3-90) months. Of the 23 patients reviewed, seven underwent endovascular treatment or open surgery due to unresponsiveness to conservative therapy, while 16 received conservative management. All patients showed regression of symptoms. Surgical patients showed a significant improvement with a 100% patency rate during the follow-up. PS matching adjusted for baseline differences, yielding comparable groups for analysis. No significant difference between treatment approaches was observed in stroke recurrence rates, although surgical intervention showed promising outcomes in symptom resolution and stroke prevention.

Conclusion: Both conservative and surgical management of CAD can lead to favorable outcomes. While conservative therapy remains the initial approach and proves effective, surgery appears beneficial and safe in certain cases unresponsive to conservative treatment. Further investigation through larger prospective and randomized trials is necessary to establish its safety and efficacy.

目的:颈动脉夹层(CAD)是年轻人中风的一个重要原因,会导致严重的并发症和社会经济负担。尽管抗血栓治疗是主要的治疗策略,但对于症状复发或恶化的患者,最佳治疗方法仍未确定。本研究旨在描述 CAD 患者保守治疗与手术治疗的特点,并评估其疗效:回顾性研究了 2014 年 11 月至 2021 年 12 月期间的 23 例 CAD 患者。收集并分析了患者的人口统计学特征、血管风险因素、症状、成像结果、治疗细节和随访信息。为增强可比性,采用了倾向得分匹配法(PSM):患者的平均年龄为 46.4 ± 9.4 岁,中位随访时间为 12 个月(3-90 个月)。在接受复查的 23 名患者中,7 人因保守治疗无效而接受了血管内治疗或开放手术,16 人接受了保守治疗。所有患者的症状都有所缓解。手术患者的症状明显改善,随访期间通畅率达到 100%。PS配对调整了基线差异,得出了具有可比性的分析组。虽然手术治疗在缓解症状和预防中风方面效果良好,但不同治疗方法在中风复发率方面无明显差异:结论:CAD 的保守治疗和手术治疗都能带来良好的疗效。结论:保守治疗和手术治疗都能带来良好的疗效。虽然保守治疗仍是最初的方法并证明有效,但在某些对保守治疗无反应的病例中,手术治疗似乎是有益和安全的。有必要通过更大规模的前瞻性随机试验进行进一步研究,以确定其安全性和有效性。
{"title":"Comparative outcomes of surgical and conservative management in carotid artery dissection.","authors":"Yuyao Feng, Zhan Zhu, Jiang Shao, Kang Li, Yiyun Xie, Lizhi Xie, Yuru Wang, Lin Wang, Huanyu Dai, Zhichao Lai, Bao Liu","doi":"10.1177/17085381241289815","DOIUrl":"10.1177/17085381241289815","url":null,"abstract":"<p><strong>Objectives: </strong>Carotid artery dissection (CAD) is a significant cause of strokes in young individuals, leading to severe complications and socioeconomic burdens. Despite antithrombotic therapy being the primary management strategy, optimal treatment for patients with recurrent or worsening symptoms remains undefined. This study aims to describe the characteristics and evaluate the outcomes of conservative versus surgical management in CAD patients.</p><p><strong>Methods: </strong>A total of 23 patients presenting with CAD from November 2014 to December 2021 were reviewed retrospectively. Patient demographics, vascular risk factors, symptoms, imaging results, treatment details, and follow-up information were collected and analyzed. Propensity score matching (PSM) was utilized to enhance comparability.</p><p><strong>Results: </strong>The mean age of the patients was 46.4 ± 9.4 years, with a median follow-up of 12 (range 3-90) months. Of the 23 patients reviewed, seven underwent endovascular treatment or open surgery due to unresponsiveness to conservative therapy, while 16 received conservative management. All patients showed regression of symptoms. Surgical patients showed a significant improvement with a 100% patency rate during the follow-up. PS matching adjusted for baseline differences, yielding comparable groups for analysis. No significant difference between treatment approaches was observed in stroke recurrence rates, although surgical intervention showed promising outcomes in symptom resolution and stroke prevention.</p><p><strong>Conclusion: </strong>Both conservative and surgical management of CAD can lead to favorable outcomes. While conservative therapy remains the initial approach and proves effective, surgery appears beneficial and safe in certain cases unresponsive to conservative treatment. Further investigation through larger prospective and randomized trials is necessary to establish its safety and efficacy.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381241289815"},"PeriodicalIF":1.0,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142378367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Embolization of a ruptured cystic artery pseudoaneurysm by percutaneous injection. 经皮注射栓塞破裂的囊性动脉假动脉瘤。
IF 1 4区 医学 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-10-04 DOI: 10.1177/17085381241289821
Fatih Hakan Tufanoğlu, Behiç Akyüz

Background: Pseudoaneurysm of the cystic artery is very rare. It usually presents with rupture and hemorrhagic shock, which may be life-threatening. Ultrasonography and contrast-enhanced tomography can be used for the diagnosis. The mainstay of treatment for this disease is cholecystectomy.

Objective: Here we present an 86-year-old man with known diabetes and Alzheimer's disease whose pseudoaneurysm was treated with percutaneous thrombin injection and highlight the technical aspect of the procedure.

Method: With ultrasonography guidance, a 21-gauge Chiba needle was passed through the liver and advanced into the pseudoaneurysm sac. A controlled, slow injection of 0.5-cc thrombin into the sac was performed with instant occlusion. Doppler imaging performed immediately following the procedure revealed that the pseudoaneurysm was not filled.

Conclusion: Pseudoaneurysm of the gallbladder is extremely rare, and its diagnosis is difficult. If the condition is not treated right away, it can quickly become life-threatening. The majority of the pseudoaneurysms have already ruptured, and the patients are clinically septic, making surgery dangerous. Also, the use of contrast media in these patients may increase the risk of nephropathy, which is not an issue with percutaneous injection. Due to the obvious risk of rupture and bleeding, we propose injecting pseudoaneurysms only if they have a visible wall.

Result: Percutaneous injection of the gallbladder pseudoaneurysms can be an option when treating gallbladder pseudoaneurysms. More research on long-term success rates is required.

背景:囊性动脉假性动脉瘤非常罕见。它通常表现为破裂和失血性休克,可能危及生命。超声波和造影剂增强断层扫描可用于诊断。目的:我们在此介绍一名患有糖尿病和阿尔茨海默病的 86 岁男性,他的假性动脉瘤是通过经皮凝血酶注射治疗的,并重点介绍了手术的技术方面:在超声引导下,将 21 号千叶针穿过肝脏,推进假性动脉瘤囊。向囊内缓慢注射 0.5 毫升凝血酶,并在瞬间闭塞。术后立即进行的多普勒成像显示,假性动脉瘤未被填塞:结论:胆囊假性动脉瘤极为罕见,而且诊断困难。如果不及时治疗,很快就会危及生命。大多数假性动脉瘤已经破裂,患者临床上处于败血症状态,因此手术非常危险。此外,对这些患者使用造影剂可能会增加肾病的风险,而经皮注射则不会出现这种问题。由于假性动脉瘤有明显的破裂和出血风险,我们建议只有在假性动脉瘤有明显的瘤壁时才对其进行注射:结果:经皮注射胆囊假性动脉瘤是治疗胆囊假性动脉瘤的一种选择。需要对长期成功率进行更多研究。
{"title":"Embolization of a ruptured cystic artery pseudoaneurysm by percutaneous injection.","authors":"Fatih Hakan Tufanoğlu, Behiç Akyüz","doi":"10.1177/17085381241289821","DOIUrl":"https://doi.org/10.1177/17085381241289821","url":null,"abstract":"<p><strong>Background: </strong>Pseudoaneurysm of the cystic artery is very rare. It usually presents with rupture and hemorrhagic shock, which may be life-threatening. Ultrasonography and contrast-enhanced tomography can be used for the diagnosis. The mainstay of treatment for this disease is cholecystectomy.</p><p><strong>Objective: </strong>Here we present an 86-year-old man with known diabetes and Alzheimer's disease whose pseudoaneurysm was treated with percutaneous thrombin injection and highlight the technical aspect of the procedure.</p><p><strong>Method: </strong>With ultrasonography guidance, a 21-gauge Chiba needle was passed through the liver and advanced into the pseudoaneurysm sac. A controlled, slow injection of 0.5-cc thrombin into the sac was performed with instant occlusion. Doppler imaging performed immediately following the procedure revealed that the pseudoaneurysm was not filled.</p><p><strong>Conclusion: </strong>Pseudoaneurysm of the gallbladder is extremely rare, and its diagnosis is difficult. If the condition is not treated right away, it can quickly become life-threatening. The majority of the pseudoaneurysms have already ruptured, and the patients are clinically septic, making surgery dangerous. Also, the use of contrast media in these patients may increase the risk of nephropathy, which is not an issue with percutaneous injection. Due to the obvious risk of rupture and bleeding, we propose injecting pseudoaneurysms only if they have a visible wall.</p><p><strong>Result: </strong>Percutaneous injection of the gallbladder pseudoaneurysms can be an option when treating gallbladder pseudoaneurysms. More research on long-term success rates is required.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381241289821"},"PeriodicalIF":1.0,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142376106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Vascular
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1